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ABSTRACT
Objectives: We aimed to evaluate the validity of the
self-reported smoking indicator used in the Global
Youth Tobacco Survey (GYTS).
Setting: 43 middle and high-school classrooms from
26 schools were selected from Mexico City and
Cuernavaca, Morelos.
Participants: A total of 1257 students provided both
a questionnaire and a urine sample.
Primary and secondary outcome: Sensitivity and
specificity of self-reported smoking compared to
urinary cotinine. Validity indices were evaluated by
subgroups of gender, social acceptability of smoking
(ie, smoking parents or friends) and smoking
frequency.
Results: Sensitivity and specificity for current
smoking were 93.2% and 81.7%, respectively. Validity
indices remained stable across gender. Parental
smoking status moderated the validity of self-report,
which had lower sensitivity in adolescents with nonsmoking parents (86.7%) than in adolescents with
smoking parents (96.6%). Sensitivity and specificity
increased with smoking frequency.
Conclusions: This first validation study of selfreported current smoking used in the GYTS among
Mexican adolescents suggests that self-reported
smoking in the past 30 days is a valid and stable
indicator of current smoking behaviour. This measure
appears suitable for public health research and
surveillance.

INTRODUCTION
Tobacco control interventions proposed by
the WHO Framework Convention on
Tobacco
Control
(WHO-FCTC)
have
reduced environmental tobacco smoke
(ETS) exposure and, to a lesser extent, the
prevalence of smoking.1 However, prevalence
deceleration has been slowing down since
2006 and policy impact has been heterogeneous across countries.2 These observations
call for a reinforcement of smoking monitoring systems, particularly in countries and
population segments where smoking behaviour has proven to be refractory to policy

Strengths and limitations of this study
▪ The WHO-Global Youth Tobacco Survey (GYTS)
is an international effort to monitor tobacco consumption in adolescents. A critical indicator in
the survey is self-reported current smoking, yet
its validity in Latin America is unknown.
▪ We evaluated the validity of self-reported
smoking in the GYTS comparing it to urinary
cotinine concentrations in 1257 Mexican adolescents. Self-reported smoking was found to be a
valid tool for epidemiological surveillance,
obtaining similar sensitivity and specificity
between genders.
▪ Small variations of validity were observed when
comparing levels of social acceptability of
smoking, finding higher sensitivity among adolescents with smoking parents; still, the sensitivity among adolescents with non-smoking
parents was satisfactory.
▪ Smoking self-report is valid and reasonably
stable across gender and contexts of social
acceptability of smoking. The increased certainty
about the validity of self-report strengthens our
confidence on GYTS-derived data for decisionmaking and the design of public policy aimed at
tobacco control in Mexico.

interventions. In Mexico, the prevalence of
adolescent smoking in 2000 was 14.5%
among youth aged 10–19 years, decreased to
10.8% in 2006 and then increased to 12.3%
in 2012.3 Surveillance of adolescent smoking
is a top priority for tobacco control,1 4 requiring affordable and valid approaches to
monitor the tobacco epidemic in this susceptible age group.
Self-report is the most common method to
assess tobacco use.5–9 However, its validity
can vary greatly across populations.7 10–12 In
adults and adolescents, the validity of selfreport has been observed to vary by gender
and perceived social acceptability of
smoking.5 7 13 14 Considering the critical
importance of self-report for tobacco surveillance and intervention research, its validity
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should be assessed for speciﬁc subpopulations to ensure
that measurement is unbiased.
The Global Youth Tobacco Survey (GYTS) is the main
international data collection effort for the epidemiological surveillance of adolescent tobacco use. The GYTS
gathers information about tobacco-related attitudes,
knowledge and behaviours, including self-reported
tobacco use, cessation and exposure to ETS.15 In Latin
America, only Brazil has assessed the validity of selfreported smoking in adolescents, ﬁnding poor performance (sensitivity of 16.3% and 22.6%).16 The validity of
self-reported current smoking in the GYTS for
Spanish-speaking Latin American countries, including
Mexico, has not yet been studied.
The present study aims to validate self-reported
smoking in Mexican adolescents using a key biomarker
of nicotine metabolism (ie, urinary cotinine), and
exploring potential differences in validity by gender,
social acceptability of smoking and frequency of
smoking.
METHODS
This validation study was undertaken simultaneously and
in parallel to the 2011 administration of the GYTS in
capital cities from 13 states of Mexico.17
GYTS sample design
The GYTS is an international survey coordinated by the
WHO aimed at the 13–15-year-old adolescent population
attending middle and high school. The GYTS has been
administered in 156 countries using standardised questions and a common methodology that facilitates comparisons across countries and over time.15 In 2011, the
GYTS was administered in Mexico selecting students in
two stages: in the ﬁrst stage, high schools were selected
with a probability proportional to the number of registered students according to the ofﬁcial active school lists
from the Public Education Ministry. In the second stage,
classrooms were randomly selected, considering the
three grades of middle school and the ﬁrst grade of
high school. All students from selected classrooms
present at the time of the survey were invited to participate. Students received full information about the study
and gave verbal assent in addition to parental informed
consent.
Participant selection for the validation study
The validation study was conducted in schools from
Mexico City and Cuernavaca. For the validation, classrooms from the same school and grade were randomly
selected among those who were not selected for the
GYTS survey, to avoid introducing ‘bogus pipeline’ bias
(ie, tendency to provide a more accurate report when
subjects are aware that an objective assessment will be
included along with self-report, as it was in the case of
our study), which would have affected the comparability
of GYTS data over time and across sites.18 19
2

Sample size was estimated to obtain a self-report
with a ±10% width in the 95% CI of the sensitivity
and speciﬁcity. However, some assumptions were
required as the cotinine-based prevalence of smoking
(‘true’ prevalence, proportion >50 ng/mL of urinary
cotinine) was unknown.20 Using data from the GYTS
2006 from Mexico City, we assumed 25% of the selfreported smokers (27.8%) would be classiﬁed as
cotinine-based smokers, given that the proportion of
regular smokers was low (2.7% smoked on 20 days or
more of the past month). Thus, the estimated sample
size was 1136 students (568 for each gender), calculated assuming a 6.75% cotinine-based prevalence of
smoking in Mexico City (same for men and women),21
with an expected sensitivity of 90% and 15% replacement. An estimated 60 classrooms with a conservative
expected average of 20 students were required to fulﬁl
the sample size.
Following the GYTS protocol, each participant
answered
an
81-question
survey
to
evaluate
tobacco-related attitudes, knowledge and behaviours,
both for cigarettes and other tobacco products. The
anonymous questionnaire was answered with no teacher
intervention. Students received full information about
the study and gave verbal assent in addition to parental
informed consent.
Self-reported smoking
The question used to establish current smoking was
“During the past 30 days (1 month), on how many days
did you smoke cigarettes?” with the GYTS predeﬁned
possible answers being: 0 days, 1–2 days, 3–5 days, 6–
9 days, 10–19 days, 20–29 days and each day for the past
30 days. Participants who answered 0 days were classiﬁed
as non-smokers, while the rest were considered as
smokers.
Cotinine
After answering the survey, participants provided a
50 mL urine sample in a vial, following protocols to
avoid dilution, contamination or sample borrowing
between students. Vials were kept at 1 to 7°C temperature and transported to the Tobacco Compounds
Analytic Laboratory from the National Institute of Public
Health in Mexico City, where they were frozen at −30°C
until analysed. Concentrations of urinary cotinine were
quantiﬁed using gas chromatography following a standard protocol.22 Two laboratory technicians were involved
in the quantitation. Urine samples were not linked to
any speciﬁc individual data, so laboratory technicians
were blind to the smoking status of the participants. The
detection limit was 16.09 ng/mL; internal and external
quality controls (blanks, duplicates, spikes) were set and
evaluated according to laboratory procedures. Urinary
cotinine constituted the gold standard to establish
tobacco use; a 50 ng/mL cut-off was used as recommended by the Nicotine and Tobacco Research
Society.23–25
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Sensitivity analyses
On the basis of a literature review, three conditions were
considered relevant to evaluate the stability of the sensitivity and speciﬁcity of self-report in this population:
Social acceptability of smoking. One of the known factors
that inﬂuence the accuracy of self-report is social restrictiveness towards smoking.5 26 We hypothesised that adolescents closely interacting with smokers were more likely to
experience an environment acceptant of smoking and
would have less pressure to conceal their smoking habits,
increasing the sensitivity of their self-report relative to
those for whom smoking is less socially acceptable. To
test this hypothesis, we obtained validity indices stratifying
adolescents by the smoking status of their parents using
the question “Do your parents, step-father, step-mother
or legal tutor smoke?” (smoking/non-smoking, at least
one parent) or by the smoking status of friends using the
question “Do any of your best friends smoke?” (smoking/
non-smoking, at least one friend).
Inﬂuence of smoking frequency. The half-life of cotinine is
19 h,27 which offsets the cotinine detection window in
relation to self-reported use (past 30 days). Thus, the sensitivity and speciﬁcity of self-report would increase with
smoking frequency. Assuming that the probability of
smoking detection by cotinine increases as the adolescent
smokes more frequently, we evaluated whether the selfreport sensitivity and speciﬁcity increased along with the
frequency of smoking. Smoking adolescents were classiﬁed in groups of frequency of smoking (1–2, 3–5, 6–9,
10–19, 20–29 days and daily) and sensitivity and speciﬁcity were estimated comparing each group to those
reporting 0 days of use in the past 30 days.
Inﬂuence of the cut-off point. A receiver operational
characteristics curve (ROC) was used to conﬁrm the

discrimination capability of the 50 ng/mL cut-off point
in Mexican adolescents compared to the 30 ng/mL
cut-off point proposed for Brazilian adolescents.28

Statistical analysis
The characteristics of the sample were described using
frequencies and percentages for categorical variables,
and median and percentiles for cotinine concentrations.
Differences in cotinine concentrations across subgroups
were explored using the non-parametric Mann-Whitney
and Kruskal-Wallis tests. Respondents were excluded
from the analysis if they had missing data or refused to
give a urine sample (n=341) (ﬁgure 1).
The overall validity of self-report was ﬁrst established
for the whole population and stratiﬁed by gender. The
validity indicators used were sensitivity ( proportion of
positive urinary cotinine respondents who reported
smoking), speciﬁcity ( proportion of negative urine cotinine respondents who reported not smoking), positive
predictive value ( probability of being a smoker if you
have a positive test) and negative predictive value ( probability of being a non-smoker if you have a negative test).
Additionally, we calculated the positive likelihood ratio
deﬁned as the probability of a positive outcome in adolescents who smoke over the likelihood of a positive
outcome in adolescents who do not smoke. An ROC
curve was built evaluating the sensitivity and 1-speciﬁcity
for self-reported smoking at different cut-off points of the
continuous urinary cotinine concentration; sensitivity,
speciﬁcity and area under the curve were estimated. CIs
were calculated at 95% for all indicators. All analyses were
conducted in STATA 12.0 (College Station, Texas, USA).

Figure 1 Study selection and
participation flow chart.
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RESULTS
From a total of 2290 students in 61 selected classrooms
from 26 schools (ﬁgure 1), 1657 (72.3%) responded to
the survey; of them, 75.8% provided urine sample and
had complete data to be included in the analyses. There
were no statistical differences between providers and
non-providers of the urine sample in terms of age or
smoking (see online supplementary table S1); a smaller
proportion of females were observed among students
who provided the urine sample (among urine providers,
51.4% were women, compared to 57.7% of
non-providers).
Table 1 describes the characteristics of students who
both responded to the questionnaire and provided a
urine sample. Of them, 51.4% were women and 72.4%
were aged 13–15 years. The majority of adolescents
reported not having smoked in the past 30 days (79.1%),
being similar for men (78.2%) and women (79.9%).
Among smokers, most smoked one cigarette per day
(73.4%), followed by those who smoked two to ﬁve cigarettes per day (21.7%) and more than six cigarettes per
day (4.9%). As for the frequency of smoking, most
smokers reported smoking 1–2 days per month (51%) or
3–5 days per month (19.8%), and 6.5% smoked daily.
There was no statistically signiﬁcant difference in the
frequency of use of smoking between men and women.

Table 1 Participant characteristics by sex
General
n=1257
Freq. (%)

Men
n=611
Freq. (%)

Age (years)
≤12
177 (14.6) 103 (17.4)
13
303 (25.1) 149 (25.2)
14
270 (22.3) 140 (23.7)
15
303 (25.1) 136 (23.0)
≥16
156 (12.9)
63 (10.7)
School grade
Seventh grade
407 (32.5) 210 (34.5)
Eighth grade
263 (21.0) 132 (21.7)
Ninth grade
377 (30.1) 185 (30.4)
First high school
206 (16.4)
81 (13.3)
Smoked in the past 30 days?
No
994 (79.1) 478 (78.2)
Yes
263 (20.9) 133 (21.8)
Number of cigarettes per day
≤1 cigarette
193 (73.4)
91 (68.4)
2–5 cigarettes
57 (21.7)
32 (24.1)
6 or more
13 (4.9)
10 (7.5)
cigarettes
Smoking days over the past 30 days
1–2 days
134 (51)
66 (49.6)
3–5 days
52 (19.8)
30 (22.6)
6–9 days
29 (11.0)
11 (8.3)
10–19 days
19 (7.2)
11 (8.3)
20–29 days
12 (4.6)
4 (3.0)
Daily
17 (6.5)
11 (8.3)
Cuernavaca and Mexico City, 2011.

4

Women
n=646
Freq. (%)
74
154
130
167
93

(12.0)*
(24.9)
(21.0)
(27.0)
(15.1)

197
131
192
125

(30.5)*
(20.3)
(29.8)
(19.4)

516 (79.9)
130 (20.1)
102 (78.5)
25 (19.2)
3 (2.3)

68
22
18
8
8
6

(52.3)
(16.9)
(13.8)
(6.2)
(6.2)
(4.6)

Table 2 shows the distribution of cotinine concentrations. Adolescents reporting smoking in the past 30 days
were more likely to have detectable concentrations of
cotinine (48.7%) and higher median cotinine (25.4 ng/
mL) than non-smoking adolescents (29.7% detectable,
median 20.5 ng/mL). Among adolescents with detectable concentrations, median cotinine increased linearly
with smoking frequency (number of days smoking per
month) and age, but not with smoking intensity
(number of cigarettes smoked per day).
Table 3 presents the results for the “During the past
30 days (one month), on how many days did you smoke cigarettes?” question, ﬁnding 93.2% sensitivity and 80.3% speciﬁcity, with an area below the ROC curve of 0.874 (raw
data for estimation available in online supplementary
table S2). Stratifying by gender the self-reported use in
the past 30 days had 95.5% sensitivity for men and 90%
for women, while speciﬁcities were 81% for men and
82.4% for women. The negative predictive value was
99.7% for the whole sample, 99.6% for women and
99.8% for men. The maximum positive likelihood was
1.8, with a 0.80 r for the whole population.
The inﬂuence of social acceptability of smoking over
self-report sensitivity and speciﬁcity is shown in ﬁgure 2.
Adolescents with smoking parents exhibited 96.6% sensitivity compared to 86.7% among adolescents with nonsmoking parents; speciﬁcity was 78.8% for adolescents
with smoking parents and 84.3% for those with nonsmoking parents. A sensitivity of 92.7% was observed
among adolescents with smoking friends, while adolescents with non-smoking friends had 100% sensitivity;
speciﬁcity was 75.3% for adolescents with smoking
friends and 96.2% for the group with non-smoking
friends.
The effect of the window of detection of cotinine over
sensitivity and speciﬁcity of self-report is presented in
online supplementary table S2. The sensitivity and speciﬁcity of those smoking 1 or 2 days per month was 62.5%
and 99.6%, respectively, increasing to 66.7% and 99.4%
among those who smoked 20 to 29 days per month, and
to 81% and 99.6% among daily smokers.
The evaluation of the cut-off point showed that the
50 ng/mL cut-off point produced the largest area under
the curve (87.4%, see online supplementary table S3).
The 30 ng/mL cut-off point produced 76% sensitivity
and 82.6% speciﬁcity, with a positive credibility of 5.0.

DISCUSSION
This study aimed to assess the validity of self-reported
smoking in the Mexican school-enrolled adolescent
population, considering differences by gender and
social restrictiveness towards smoking. The standard
question used worldwide to classify youth as current
smokers (ie, “During the past 30 days (one month), on how
many days did you smoke cigarettes?”) had 93.2% sensitivity
and 81.7% speciﬁcity, which were similar for males and
females.
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Table 2 Per cent and cotinine concentration distribution of adolescents above the cotinine limit of detection (16.09 ng/mL)
>LOD°
n

%

Self-reported smoking (past 30 days)
Non-smoker
295
29.7
Smoker
128
48.7
Age (years old)
≤12
53
29.9
13
102
33.7
14
79
29.3
15
99
32.7
≥16
80
51.3
School grade
Seventh grade
123
30.2
Eighth grade
85
32.3
Ninth grade
128
34
First high school
86
41.8
Number of cigarettes per day
0 cigarettes
292
29.5
1 cigarette
87
45.3
2–5 cigarettes
35
61.4
6 and more
5
38.5
Smoking days over the past 30 days
0 days
290
29.2
1–2 days
52
38.8
3–5 days
23
44.2
6–9 days
15
51.7
10–19 days
15
78.9
20–29 days
10
83.3
Daily
13
76.5

General (n=423)
Med (P25, P75)

Men (n=214)
Med (P25, P75)

Women (n=209)
Med (P25, P75)

20.5 (17.5, 22.8)*
25.4 (19.6, 72.5)

19.3 (17.4, 22.6)
26 (20.4, 71.6)

21.3 (18.0, 23.1)
24.7 (18.2, 84.9)

20.9 (17.9,
21.2 (17.5,
21.0 (17.7,
21.0 (17.9,
23.6 (19.9,

23.2)*
23.6)
22.9)
24.6)
69.5)

21.1 (18.1, 23,8)
21.0 (17.6, 23.8)
18.7 (17.5, 22.4)
20.5 (17.5, 22.4)
25.7 (19.9, 72.5)

18.8
21.6
21.8
21.5
22.1

(17.7, 22.6)
(16.9, 23.6)
(19.5, 24.3)
(17.8, 24.5)
(19.9, 67.7)

20.8 (17.8,
21.2 (17.7,
21.6 (18.2,
23.2 (18.1,

23.1)
23.2)
25.2)
70.7)

21.3 (18.0, 23.5)
18 (17.4, 21.3)
21.6 (18.1, 30.3)
26 (18.6, 30.3)

19.1
22.3
21.6
21.3

(17.0, 22.8)
(20.9, 25.7)
(18.2, 23.8)
(18.0, 64.4)

20.5 (17.5,
23.7 (18.3,
68.4 (25.5,
24.3 (17.2,

22.9)*
40.0)
170.3)
1022.8)

19.4 (17.5, 22.8)
24.6 (19.4, 50.4)
41 (24.1, 226.1)
21 (17.0, 892.6)

21.0 (18.0, 22.9)
22.3 (18.1, 37.1)
108.9 (60.3, 163.4)
863.4 (863.4, 863.4)

19.4 (17.5, 22.8)
24.0 (17.7, 31.0)
26.0 (21.3, 48.4)
21.6 (18.3, 356.9)
25.5 (19.0, 69.8)
30.1 (22.2, 47.0)
371.1 (279.6, 448.3)

21.3 (18.1, 22.9)
22.1 (17.9, 24.7)
28.1 (16.7, 48.1)
41.7 (23.2, 97.6)
119.8 (22.8, 316.5)
171.3 (157.1, 527.9)
66.6 (63.1, 466.2)

20.7 (17.8, 22.9)*
22.4 (17.8, 26.3)
26.0 (20.9, 48.4)
26.3 (18.6, 110.3)
30.7 (19.5, 130.6)
107.2 (23.5, 172.9)
329.4 (170.3, 448.3)

Cuernavaca and Mexico City, 2011.
During the past 30 days (1 month), on how many days did you smoke cigarettes?”.
*p Value<0.05.
LOD, limit of detection.

These results are consistent with other studies that have
used urinary cotinine with the same cut-off point.6 29
Using the 50 ng/mL cut-off in Canadian adolescents,
Wong estimated an 81.6% sensitivity and a 96.9% speciﬁcity,29 while Park and Kim6 observed an 85.7% sensitivity
and a 100% speciﬁcity in Korea. In 13 and 14-year old
Brazilian teenagers, Malcon et al28 found a 22.6% sensitivity and a 93.7% speciﬁcity; however, even though the
Brazilian study assessed urinary cotinine, investigators
used the 30 ng/mL cut-off commonly used for saliva
samples, which could explain the poor performance of
self-report. Although the selected cut-off point of urine
cotinine for discriminating use was obtained under near

experimental conditions,30 diverse studies have suggested
that the selection of the cut-off point of 50 ng/mL may
not be adequate for all populations.16 In our population,
the best cut-off point was found at 50 ng/mL.
Self-reported smoking behaviour can underestimate
true smoking prevalence and quantity due to socially
desirable responding.26 31 32 The main validity threat to
self-reported smoking in adolescents is the higher probability of under-reporting smoking behaviour when
survey administration occurs in a context of social disapproval of smoking.31 33 34 To test this, our adolescent
population was stratiﬁed by parental smoking status and,
as expected, we found a lower sensitivity among students

Table 3 Criterion validity of current self-reported smoking*
All
Men
Women

Sensitivity

Specificity

PPV

NPV

LR(+)

93.2 (80.3–98.2)
95.5 (75.1–99.2)
90.9 (69.4–98.4)

81.7 (77.9–82.6)
81.0 (77.5–84.0)
82.4 (79.1–85.2)

15.2 (11.2–20.2)
15.8 (10.3–23.4)
15.4 (9.9–23.0)

99.7 (98.9–99–9)
99.8 (98.7–99–9)
99.6 (98.5–99.9)

5.1
5.0
5.2

Cuernavaca and Mexico City, 2011.
*Compared to urinary cotinine concentration (cut-off 50 ng/mL).
LR(+) positive likelihood ratio; NPV, negative predictive value; PPV, positive predictive value.
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Figure 2 Sensitivity analyses for
self-reported current smoking.
Cuernavaca and Mexico City,
2011.

from families where parents did not smoke compared to
those where parents smoked (86.7% and 96.6%, respectively), although speciﬁcity was more comparable across
both groups (78.6% and 84.6%, respectively). When
assessing the potential inﬂuence of friend smoking on
validity, the effects were less notable, with similar sensitivities and speciﬁcities between teenagers with and
without smoking friends.
Cotinine is considered the most precise biomarker of
nicotine exposure and, by extension, tobacco use in the
prior 2 days,7 being more speciﬁc and bioavailable than
other biomarkers.13 35–37 However, cotinine half-life is
19 h, providing a short window of detection to evaluate
use that occurs over longer periods of time.5 The
narrow detection window seems to not affect the sensitivity, as those reaching the threshold for the cotinine test
declared themselves as smokers; however, this limitation
does imply a decrease in speciﬁcity (as 18.3% of
cotinine-negative adolescents self-report as smokers)
and, particularly, a decrease in the positive predictive
value (only 15.6% of smokers were positive to the cotinine test). Consistent with this observation, the positive
predictive value increased as with the frequency of
smoking (see online supplementary table S2). Urinary
cotinine is a valuable gold standard, being particularly
suitable to evaluate recent use; yet, it has some limitations to classify occasional smokers (eg, weekly or
monthly smokers). Other biological substrates, such as
hair, could provide longer windows of detection,
although this beneﬁt must be weighed against the difﬁculties to obtain a sample, as the procedure is invasive
and prone to induce selection bias.5 13 38 Cigarette
smoking is not the only source of urinary cotinine,24
and exposure to ETS could inﬂuence the sensitivity and
6

speciﬁcity of self-report. Stratifying our sample by ETS
exposure at home over the past 7 days showed a higher
sensitivity (96.7%) but lower speciﬁcity of self-report
(77.4%) among those exposed at least one day in the
previous week compared to those unexposed (sensitivity
85.7%, speciﬁcity 84.8%; data available in online
supplementary table S4). This difference is explained by
the differential effect of ETS exposure over urinary cotinine in smokers and non-smokers. Smokers exposed to
ETS have higher concentrations of cotinine than unexposed smokers, but ETS exposure has a smaller inﬂuence over the urinary cotinine concentration of
non-smokers (see online supplementary table S5); thus,
ETS exposure should increase the proportion of participants over 50 ng/mL of urinary cotinine, but most of
them will be self-reported smokers increasing the sensitivity at the expense of lower speciﬁcity. While this difference exists, the self-reported smoking is still acceptable
for both ETS exposed and unexposed; caution should
be exerted when considering this sensitivity analysis as
the size of the cells becomes small due to the association
between smoking and ETS exposure.
Some limitations must be mentioned regarding our
ﬁndings. The validation took place in two cities with a
relatively high smoking prevalence, Mexico City (21.8%)
and Cuernavaca (24.4%), compared to a 14.6% nationwide estimate.17 A higher prevalence suggests higher
social acceptability of smoking in the analytic sample for
this study, which could potentially limit the generalisability of our ﬁndings. However, self-reported current
smoking maintained adequate sensitivity and speciﬁcity
across contexts with varying degrees of social acceptability, as seen in adolescents with smoking and nonsmoking parents or friends. Thus, self-report should
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perform adequately in Mexican states with higher social
restrictiveness towards smoking. The GYTS was applied
in school environments, eliminating the inﬂuence of
parents observed in home surveys but excluding adolescents who do not attend school.9 In Mexico, education
is mandatory until high school is completed. School
attendance in the age group targeted by the GYTS is
high (92%) up to age 14, but then decreases (63%) for
those aged 15–17 years.39 Therefore, although this validation study applies to the vast majority of Mexican teenagers, further conﬁrmation is needed for adolescents
aged 15 years and older. Finally, the prevalence of
cotinine-based smoking was lower than expected (3.5%
of the sample was above the 50 ng/mL cut-off point), as
a reﬂection of the large proportion of occasional
smokers among Mexican adolescents and of the selfreported smoking prevalence reduction observed
between 2006 and 2011 in Mexico City and Cuernavaca;
therefore, our CIs were larger than the expected ±10%
deﬁned in our sample size calculation.
Self-report of tobacco use constitutes a fundamental
tool for tobacco monitoring systems and research. This
study is the ﬁrst among Spanish-speaking Latin
American countries to assess the validity of the most
commonly used method for assessing current smoking
behaviour among adolescents, suggesting that this
approach is valid and reasonably stable across sex and
contexts with different levels of the social acceptability
of smoking. Therefore, adolescent smoking self-report
constitutes a valid approximation to assess smoking
behaviour. The increased certainty about the validity of
self-report strengthens our conﬁdence on the
GYTS-derived data for decision-making and the design
of public policy aimed at tobacco control in Mexico.
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